Outcomes of patients with therapy-related myeloid neoplasms after treatment with poly(ADP-ribose) polymerase proteins inhibitors for solid tumours.
Saved in:
| Title: | Outcomes of patients with therapy-related myeloid neoplasms after treatment with poly(ADP-ribose) polymerase proteins inhibitors for solid tumours. |
|---|---|
| Authors: | Almanza-Huante E; Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA., Bataller A; Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA., Urrutia S; Cancer Medicine, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA., Gener-Ricos G; Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA., Briski RE; Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA., Kanagal-Shamanna R; Department of Hematopathology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA., Lu KH; Department of Gynecologic Oncology and Reproductive Medicine, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA., Westin SN; Department of Gynecologic Oncology and Reproductive Medicine, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA., Yap TA; Department of Investigational Cancer Therapeutics (Phase I Program), MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA., Takahashi K; Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA., Ravandi F; Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA., Alvarado Y; Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA., Kadia T; Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA., Sasaki K; Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA., Kantarjian HM; Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA., Garcia-Manero G; Department of Leukemia, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. |
| Source: | British journal of haematology [Br J Haematol] 2023 May; Vol. 201 (3), pp. e25-e29. Date of Electronic Publication: 2023 Mar 23. |
| Publication Type: | Letter; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1365-2141 |
|---|---|
| DOI: | 10.1111/bjh.18766 |
